A unique case of mefloquine-induced psoriasis

Journal of Travel Medicine

Volumn 5, Issue 3, 1998, Pages 156-

  Potasman, Israel ^a,b   Seligmann, Hanna ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; MEFLOQUINE; MEPACRINE; PROGUANIL; QUINIDINE;

ADULT; ANXIETY; ARTICLE; CASE REPORT; DRUG MECHANISM; DRUG SAFETY; HUMAN; HUMAN CELL; HUMAN TISSUE; KENYA; LATENT PERIOD; MALARIA; MALE; PSORIASIS; TRAVEL;

ANTIMALARIALS; ANXIETY; HUMANS; MALE; MEFLOQUINE; MIDDLE AGED; PSORIASIS; TRAVEL;

EID: 0031670007     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.1998.tb00492.x     Document Type: Article

References (7)

1. Vine JE, Hymes SR, Warner NB, Cohen PR. Pustular psoriasis induced by hydroxychloroquine: a case report and review of the literature. J Dermal 1996; 23:357-361.
2. Ziprowski L, Haim L, Bank H. Atabrine in psoriasis. Acta Med Orient 1954; 13:45-52.
3. Gold MH, Holy AK, Roenigk HH. Beta blocking drugs and psoriasis. J Am Acad Dermatol 1988; 19:837-841.
4. Deandrea D, Walker N, Mehlmauer M, et al. Dermatological reactions to lithium: a critical review of the literature. J Clin Psychopharmacol 1982; 2:199-203.
5. Barret PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travelers. BMJ 1996; 313:525-528.
6. Al'Abadie MS, Kent GG, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994; 130:199-203.
7. Farber EM, Nall L. Psoriasis: a stress related disease. Cutis 1993; 51:322-326.